Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,375 across all filing types
Latest filing 2020-05-21 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, Yanzhou Coal Mining Company Limited, reporting changes in issued share capital and share buybacks. It includes detailed information on share repurchases, issued shares, prices, and confirmations related to compliance with listing rules. The content focuses on share capital changes and repurchase activities, which aligns with announcements regarding share repurchases or capital changes. The document is not a full financial report but a regulatory disclosure about share capital changes and buybacks. Therefore, it fits the category of Transaction in Own Shares (POS). The document length (8330 characters) supports it being a detailed disclosure rather than a brief announcement or a full annual/interim report.
2020-05-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CStone Pharmaceuticals, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to employee share option exercises and share repurchases, with dates and quantities. The document references compliance with Listing Rules of the Hong Kong Stock Exchange and confirms authorization by the board of directors. It is a regulatory disclosure about share capital changes and share repurchases, not a full financial report or earnings release. The content fits the definition of a Transaction in Own Shares (POS) filing, as it reports on share buybacks and share issues related to employee options. The document length (9612 characters) and detailed transactional data support this classification rather than a brief announcement or a general regulatory filing.
2020-05-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by Yanzhou Coal Mining Company Limited. It includes detailed information about share repurchases, issued shares, prices, and confirmations of compliance with listing rules. The document is structured as a regulatory disclosure form for share capital changes and share repurchases, not a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the stock exchange. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2020-05-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by Yanzhou Coal Mining Company Limited. It includes detailed information about share repurchases, issued shares, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share capital changes and repurchases, not a financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2020-05-19 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by Yanzhou Coal Mining Company Limited. It includes detailed information on share repurchases, share cancellations, and confirmations that these actions comply with listing rules. The document is structured as a regulatory disclosure form submitted to the stock exchange, focusing on capital changes and share repurchase activities. It does not contain financial statements, earnings data, or management discussion, nor is it a report or presentation. Therefore, it fits best under the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2020-05-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CStone Pharmaceuticals, detailing changes in issued share capital and share buybacks. It includes specific data on share issues, repurchases, prices, and confirmations related to compliance with listing rules. The content focuses on share capital changes and repurchase activities, with no financial statements or earnings data. This matches the definition of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length (9100 characters) and detailed transactional data support this classification rather than a simple announcement or regulatory filing. Therefore, the appropriate classification is POS with high confidence.
2020-05-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.